JAHA Spotlight on Racial and Ethnic Disparities in Cardiovascular Disease
2021; Wiley; Volume: 10; Issue: 17 Linguagem: Inglês
10.1161/jaha.121.023650
ISSN2047-9980
AutoresSula Mazimba, Pamela N. Peterson,
Tópico(s)Cardiovascular Health and Risk Factors
ResumoHomeJournal of the American Heart AssociationVol. 10, No. 17JAHA Spotlight on Racial and Ethnic Disparities in Cardiovascular Disease Open AccessResearch ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citations ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toOpen AccessResearch ArticlePDF/EPUBJAHA Spotlight on Racial and Ethnic Disparities in Cardiovascular Disease Sula Mazimba and Pamela N. Peterson Sula MazimbaSula Mazimba https://orcid.org/0000-0001-6451-2118 , University of Virginia, , Charlottesville, , VA, and Pamela N. PetersonPamela N. Peterson * Correspondence to: Pamela N. Peterson, MD, MSPH, Denver Health Medical Center, 777 Bannock St, MC 0960, Denver, CO 80204. E‐mail: E-mail Address: [email protected] https://orcid.org/0000-0001-6864-2016 , Denver Health Medical Center, , Denver, , CO, , University of Colorado Anschutz Medical Center, , Aurora CO, Originally published25 Aug 2021https://doi.org/10.1161/JAHA.121.023650Journal of the American Heart Association. 2021;10:e023650Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: August 25, 2021: Ahead of Print Cardiovascular diseases (CVD), principally ischemic heart disease and stroke, are the leading cause of death in the United States.1 Although management of CVD has led to improved mortality over the years, striking disparities in outcomes have persisted and widened among racial and ethnic groups.2, 3 These disparities segregate along the lines of race and ethnicity, socioeconomic status, and geography.4 Health disparities, as defined by the World Health Organization, are "systematic, socially produced (and therefore modifiable) and unfair"5 conditions that disproportionately affect historically underrepresented racial and ethnic groups.6 For example, the burden of cardiovascular disease in Black communities remains disproportionately high and is a primary cause of disparities in life expectancy between Black and White individuals.7 Approximately 30% of the mortality difference between Black and White men and 40% of the difference between Black and White women is driven by disparities in CVD outcomes.8In this issue of the Journal of the American Heart Association (JAHA), we feature a compendium of articles highlighting health disparities across a spectrum of CVD conditions. These disparities are principally attributable to social determinants of health and the complex interplay of structural racism on the health of people from underrepresented communities.9 These pervasive societal ills negatively influence health outcomes across the lifespan.10Several articles in this spotlight examine the prevalence and outcomes of cardiovascular risk factors, with some focusing on prepregnancy and pregnancy related risk factors. In a large cross‐sectional study, Zheng et al highlight racial, ethnic and geographic disparities in cardiovascular health among women of childbearing age using data from the 2011–2019 Behavioral Risk Factor Surveillance survey.11 Using the American Heart Association's Life Simple 7 (blood pressure, glucose, total cholesterol, smoking, body mass index, physical activity, and diet) to determine ideal cardiovascular metrics in over 269 000 participants, the authors found large racial, ethnic, and geographical disparities in cardiovascular health, with the disparities being most pronounced among non‐Hispanic Black women, with regional clustering (most prominent in southern states). Wang et al also highlight concerning findings of the increasing prevalence of prepregnancy obesity across all major ethnic groups in the United States as well as the attendant increase in pregnancy‐associated adverse outcomes (preterm birth, low birth weight, and pregnancy‐associated hypertension).12 Experimental studies13 support causal effects of maternal obesity on offspring outcomes, which are mediated at least partly through changes in epigenetic processes. Malek and colleagues also examine the association of hypertensive disorders of pregnancy and prepregnancy hypertension with maternal incident heart failure within 5 years of delivery.14 They also investigated differential outcomes of these exposures based on race and ethnicity. The authors demonstrate higher incident heart failure in non‐Hispanic Black women than non‐Hispanic White women. These findings underscore the troubling, disproportionately high burden of increased cardiovascular risk factors among people of childbearing age who are part of underrepresented racial or ethnic groups (especially Black women). The implications of this heightened cardiovascular risk factor burden in women of childbearing age on both maternal and offspring outcomes can have far reaching impact beyond the proximate postpartum period (resulting in premature onset of CVD downstream).15, 16 In addition to the articles focusing on prepregnancy and pregnancy related risk factors, Agarwala and colleagues evaluated racial differences in predictors of CVD among patients with familial hypercholesterolemia.17 They found that Black patients had a higher prevalence of modifiable risk factors and that hypertension and smoking were particularly strong predictors of CVD. Thus, the preponderance of CVD risk factors among people from underrepresented racial and ethnic groups is not only restricted to women of childbearing age, but in all segments of the population and across a wide spectrum of disease conditions.7, 18Access to high quality healthcare is an important fundamental driver underlying healthcare disparities.19 Patients who belong to underrepresented racial and ethnic groups confront more barriers to CVD diagnosis and care, receive less optimal care, and experience worse adverse outcomes than White patients.4 Chouairi et al20 with an accompanying editorial by Lewsey and Breathett,21 highlight contemporary trends in adult heart transplant outcomes among patients from different racial and ethnic groups in the United States. Compared with White patients, Black patients were still less likely to undergo transplantation and had a higher risk of posttransplant death despite recent amendments to the United Network for Organ Sharing (UNOS). These vexing trends of differential access to and receipt of quality healthcare are not only confined to adult heart transplant patients; they are also reflected in studies highlighted in this issue of patients with other CVD conditions, including post cardiac arrest, as described by Moeller et al22; postacute myocardial infarction among young and middle age adults as described by Raparelli et al23 and Garcia et al24; receipt of anticoagulation after electrical cardioversion for atrial fibrillation and flutter as described by Mentias et al25; severity of pulmonary embolism and likelihood of receipt of interventional therapies as described by Phillips et al26; and lower extremity amputations among Black patients living in metropolitan areas with close proximity to centers with specialty care for peripheral artery disease as described by Fanaroff et al.27 These disparities may be driven by factors such as bias, stereotyping, and prejudice against underrepresented minority populations.28 The differential access to quality health care is pervasive and occurs in the broader context of historic and contemporary social and economic practices and policies that have led to inequalities across many US healthcare systems.Ascertainment of disease and outcomes, especially among patients from racial or ethnic minority groups, may also be an important driver of health care disparities.29 For example, adverse outcomes associated with atrial fibrillation have predominantly been investigated in White cohorts. In one study with diverse patient representation, the prospective ARIC (Atherosclerosis Risk in Communities) study of patients with atrial fibrillation, the rates of stroke, heart failure, coronary heart disease, and mortality were higher in Black individuals than White individuals.30 In this sense, increased representation of underrepresented racial or ethnic groups is critical to enhancing provider understanding of CVD risk in order to inform nuanced optimal care to people who belong to those groups. Prasanna et al31 and the accompanying editorial by Lakdawala32 underscore a ubiquitous problem of racial and ethnic underrepresentation in clinical trials. Again, Arabadjian et al,33 with editorial remarks by Lakdawala,32 point to important differences in hypertrophic cardiomopathy disease presentation and adverse outcomes and the urgent need for inclusion of Black populations in clinical trials. Similarly, Walker et al34 demonstrate a signal for potential association of white matter disease and amyloid deposition in the pathogenesis of Alzheimer's disease. Berglund et al35 also report genetic variations in the interaction of lipoprotein (a), oxidized phospholipids alleles specific expression, and heritability differences in cohorts of Black patients. It is important to note that race is a social construct and not a biological determinant of disease and that race and ethnicity are a proxy of socioeconomic status.36 The biological differences in disease expression in diverse populations underscore the promise of precision medicine through polygenic risk scores for better disease phenotype and risk stratification. However, many racial and ethnic groups are still grossly underrepresented in genome‐wide association studies that have hitherto been focused primarily on populations of European ancestry.37 Falcone and colleagues report from All of Us, a program that aims to accelerate research in populations traditionally underrepresented in biomedical research.38 They found an increased burden of CVD among participants who were Black, older age, disabled, and of lower income. All of Us is a national program in which participants agree to share their electronic health record data, complete surveys, and provide biospecimens. This is a promising resource to advance research in health disparities.We hope that this JAHA Spotlight will reinforce the American Heart Association's recent Presidential Advisory urging all stakeholders to a "committed path towards transforming the conditions of historically marginalized communities, improving the quality of housing and neighborhood environments of these populations, advocating for policies that eliminate inequities in access to economic opportunities, quality education, and health care, and enhancing allyship among racial and ethnic groups."6 As David Livingstone once said, "Sympathy is no substitute for action." Concerted action among all stakeholders will be needed to ensure progress toward health equity for all people.DisclosuresNone.Footnotes* Correspondence to: Pamela N. Peterson, MD, MSPH, Denver Health Medical Center, 777 Bannock St, MC 0960, Denver, CO 80204. E‐mail: pamela.peterson@cuanschutz.eduThe opinions expressed in this article are not necessarily those of the American Heart Association.References1 Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Cheng S, Delling FN, et al.; American Heart Association Council on E, Prevention Statistics C and Stroke Statistics S . Heart disease and stroke statistics‐2021 update: a report from the American Heart Association. Circulation. 2021; 143:e254–e743. doi: 10.1161/CIR.0000000000000950LinkGoogle Scholar2 Glynn P, Lloyd‐Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in cardiovascular mortality related to heart failure in the United States. J Am Coll Cardiol. 2019; 73:2354–2355. doi: 10.1016/j.jacc.2019.02.042CrossrefMedlineGoogle Scholar3 Singh GK, Siahpush M, Azuine RE, Williams SD. Widening socioeconomic and racial disparities in cardiovascular disease mortality in the United States, 1969–2013. Int J MCH AIDS. 2015; 3:106–118.MedlineGoogle Scholar4 Bonow RO, Grant AO, Jacobs AK. The cardiovascular state of the union: confronting healthcare disparities. Circulation. 2005; 111:1205–1207. doi: 10.1161/01.CIR.0000160705.97642.92LinkGoogle Scholar5 Whitehead M, Dahlgren G; World Health Organization . Concepts and principles for tackling social inequalities in health: leveling up (part. 1). 2006.Google Scholar6 Churchwell K, Elkind MSV, Benjamin RM, Carson AP, Chang EK, Lawrence W, Mills A, Odom TM, Rodriguez CJ, Rodriguez F, et al. Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American Heart Association. Circulation. 2020; 142:e454–e468. doi: 10.1161/CIR.0000000000000936LinkGoogle Scholar7 Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA, Willis M, et al.; American Heart Association Council on Epidemiology and Prevention; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council . Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017; 136:e393–e423.LinkGoogle Scholar8 Gillespie CD, Wigington C, Hong Y; Centers for Disease C and Prevention . Coronary heart disease and stroke deaths—United States, 2009. MMWR Suppl. 2013; 62:157–160.MedlineGoogle Scholar9 Jones CP. Levels of racism: a theoretic framework and a gardener's tale. Am J Public Health. 2000; 90:1212–1215.CrossrefMedlineGoogle Scholar10 Marmot M, Friel S, Bell R, Houweling TA, Taylor S; Commission on Social Determinants of Health . Closing the gap in a generation: health equity through action on the social determinants of health. Lancet. 2008; 372:1661–1669. doi: 10.1016/S0140‐6736(08)61690‐6CrossrefMedlineGoogle Scholar11 Zheng Y, Wen X, Bian J, Zhao J, Lipkind HS, Hu H. Racial, ethnic, and geographic disparities in cardiovascular health among women of childbearing age in the United States. J Am Heart Assoc. 2021; 10:e020138. doi: 10.1161/JAHA.120.020138LinkGoogle Scholar12 Wang MC, Freaney PM, Perak AM, Greenland P, Lloyd‐Jones DM, Grobman WA, Khan SS. Trends in prepregnancy obesity and association with adverse pregnancy outcomes in the United States, 2013–2018. J Am Heart Assoc. 2021; 10:e020717. doi: 10.1161/JAHA.120.020717LinkGoogle Scholar13 Godfrey KM, Reynolds RM, Prescott SL, Nyirenda M, Jaddoe VW, Eriksson JG, Broekman BF. Influence of maternal obesity on the long‐term health of offspring. Lancet Diabetes Endocrinol. 2017; 5:53–64. doi: 10.1016/S2213‐8587(16)30107‐3CrossrefMedlineGoogle Scholar14 Malek AM, Wilson DA, Turan TN, Mateus J, Lackland DT, Hunt KJ. Incident heart failure within the first and fifth year of delivery among women with hypertensive disorders of pregnancy and prepregnancy hypertension in a diverse population. J Am Heart Assoc. 2021; 10:e021616. doi: 10.1161/JAHA.121.021616LinkGoogle Scholar15 Varagic J, Desvigne‐Nickens P, Gamble‐George J, Hollier L, Maric‐Bilkan C, Mitchell M, Pemberton VL, Redmond N. Maternal morbidity and mortality: are we getting to the "heart" of the matter?J Womens Health (Larchmt). 2021; 30:178–186. doi: 10.1089/jwh.2020.8852CrossrefMedlineGoogle Scholar16 Palinski W. Effect of maternal cardiovascular conditions and risk factors on offspring cardiovascular disease. Circulation. 2014; 129:2066–2077. doi: 10.1161/CIRCULATIONAHA.113.001805LinkGoogle Scholar17 Agarwala A, Bekele N, Deych E, Rich MW, Hussain A, Laney K, Jones LK, Sturm AC, Aspry K, Nowak E, et al. Racial disparities in modifiable risk factors and statin usage in Black patients with familial hypercholesterolemia. J Am Heart Assoc. 2021; 10:e020890. doi: 10.1161/JAHA.121.020890LinkGoogle Scholar18 Min YI, Anugu P, Butler KR, Hartley TA, Mwasongwe S, Norwood AF, Sims M, Wang W, Winters KP, Correa A. Cardiovascular disease burden and socioeconomic correlates: findings from the Jackson Heart Study. J Am Heart Assoc. 2017; 6:e004416. doi: 10.1161/JAHA.116.004416LinkGoogle Scholar19 Eisenberg JM, Power EJ. Transforming insurance coverage into quality health care: voltage drops from potential to delivered quality. JAMA. 2000; 284:2100–2107. doi: 10.1001/jama.284.16.2100CrossrefMedlineGoogle Scholar20 Chouairi F, Fuery M, Clark KA, Mullan CW, Stewart J, Caraballo C, Clarke J‐RD, Sen S, Guha A, Ibrahim NE, et al. Evaluation of racial and ethnic disparities in cardiac transplantation. J Am Heart Assoc. 2021; 10:e021067. doi: 10.1161/JAHA.120.021067LinkGoogle Scholar21 Lewsey SC, Breathett K. Equity in heart transplant allocation: intended progress up the hill or an impossibility?J Am Heart Assoc. 2021; 10:e022817. doi: 10.1161/JAHA.121.022817LinkGoogle Scholar22 Moeller S, Hansen CM, Kragholm K, Dupre ME, Sasson C, Pearson DA, Tyson C, Jollis JG, Monk L, Starks MA, et al. Race differences in interventions and survival after out‐of‐hospital cardiac arrest in North Carolina, 2010–2014. J Am Heart Assoc. 2021; 10:e019082. doi: 10.1161/JAHA.120.019082LinkGoogle Scholar23 Raparelli V, Benea D, Nunez Smith M, Behlouli H, Murphy TE, D'Onofrio G, Pilote L, Dreyer RP. Impact of race on the in‐hospital quality of care among young adults with acute myocardial infarction. J Am Heart Assoc. 2021; 10:e021408. doi: 10.1161/JAHA.121.021408LinkGoogle Scholar24 Garcia M, Almuwaqqat Z, Moazzami K, Young A, Lima BB, Sullivan S, Kaseer B, Lewis TT, Hammadah M, Levantsevych O, et al. Racial disparities in adverse cardiovascular outcomes after a myocardial infarction in young or middle‐aged patients. J Am Heart Assoc. 2021; 10:e020828. doi: 10.1161/JAHA.121.020828LinkGoogle Scholar25 Mentias A, Nakhla S, Desai M, Wazni O, Menon V, Kapadia S, Vaughan Sarrazin . Racial and sex disparities in anticoagulation after electrical cardioversion for atrial fibrillation and flutter. J Am Heart Assoc. 2021; 10:e021674. doi: 10.1161/JAHA.121.021674LinkGoogle Scholar26 Phillips AR, Reitz KM, Myers S, Thoma F, Andraska EA, Jano A, Sridharan N, Smith RE, Mulukutla SR, Chaer R. Association between Black race, clinical severity, and management of acute pulmonary embolism—retrospective cohort study. J Am Heart Assoc. 2021; 10:e021818. doi: 10.1161/JAHA.121.021818LinkGoogle Scholar27 Fanaroff AC, Yang L, Nathan AS, Khatana SAM, Julien H, Wang TY, Armstrong EJ, Treat‐Jacobson D, Glaser JD, Wang G, et al. Geographic and socioeconomic disparities in major lower extremity amputation rates in metropolitan areas. J Am Heart Assoc. 2021; 10:e021456. doi: 10.1161/JAHA.121.021456LinkGoogle Scholar28 Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc. 2002; 94:666–668.MedlineGoogle Scholar29 Babulal GM, Quiroz YT, Albensi BC, Arenaza‐Urquijo E, Astell AJ, Babiloni C, Bahar‐Fuchs A, Bell J, Bowman GL, Brickman AM, et al.; International Society to Advance Alzheimer's R and Treatment AsA . Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need. Alzheimers Dement. 2019; 15:292–312. doi: 10.1016/j.jalz.2018.09.009CrossrefMedlineGoogle Scholar30 Magnani JW, Norby FL, Agarwal SK, Soliman EZ, Chen LY, Loehr LR, Alonso A. Racial differences in atrial fibrillation‐related cardiovascular disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA Cardiol. 2016; 1:433–441. doi: 10.1001/jamacardio.2016.1025CrossrefMedlineGoogle Scholar31 Prasanna A, Miller HN, Wu Y, Peeler A, Ogungbe O, Plante TB, Juraschek SP. Recruitment of Black adults into cardiovascular disease trials. J Am Heart Assoc. 2021; 10:e021108. doi: 10.1161/JAHA.121.021108LinkGoogle Scholar32 Lakdawala NK. Separate and unequal: cardiovascular medicine in Black Americans. J Am Heart Assoc. 2021; 10:e022841. doi: 10.1161/JAHA.121.022841LinkGoogle Scholar33 Arabadjian M, Yu G, Sherrid MV, Dickson VV. Disease expression and outcomes in Black and White adults with hypertrophic cardiomyopathy. J Am Heart Assoc. 2021; 10:e019978. doi: 10.1161/JAHA.120.019978LinkGoogle Scholar34 Walker KA, Silverstein N, Zhou Y, Hughes TM, Jack CR, Knopman DS, Sharrett AR, Wong DF, Mosley TH, Gottesman RF. Brain white matter structure and amyloid deposition in Black and White older adults: the ARIC‐PET Study. J Am Heart Assoc. 2021; 10:e022087. doi: 10.1161/JAHA.121.022087LinkGoogle Scholar35 Berglund L, Kim K, Zhang W, Prakash N, Truax K, Anuurad E, Enkhmaa B. Lp(a)‐associated oxidized phospholipids in healthy Black and White participants in relation to apo(a) size, age, and family structure. J Am Heart Assoc. 2021; 10:e020158. doi: 10.1161/JAHA.120.020158LinkGoogle Scholar36 Cooper RS. Race in biological and biomedical research. Cold Spring Harb Perspect Med. 2013; 3:a008573. doi: 10.1101/cshperspect.a008573CrossrefMedlineGoogle Scholar37 Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019; 51:584–591. doi: 10.1038/s41588‐019‐0379‐xCrossrefMedlineGoogle Scholar38 Acosta JN, Leasure AC, Both CP, Szejko N, Brown S, Torres‐Lopez V, Abdelhakim S, Schindler J, Petersen N, Sansing L, et al. Cardiovascular health disparities in racial and other underrepresented groups: initial results from the All of Us research program. J Am Heart Assoc. 2021; 10:e021724. doi: 10.1161/JAHA.121.021724LinkGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Maroney K, Laurent J, Alvarado F, Gabor A, Bell C, Ferdinand K, He J and Mills K (2023) Systematic review and meta-analysis of church-based interventions to improve cardiovascular disease risk factors, The American Journal of the Medical Sciences, 10.1016/j.amjms.2023.05.010, 366:3, (199-208), Online publication date: 1-Sep-2023. Formanack A, Doshi A, Valdez R, Williams I, Moorman J and Chernyavskiy P (2023) Race, Class, and Place Modify Mortality Rates for the Leading Causes of Death in the United States, 1999–2021, Journal of General Internal Medicine, 10.1007/s11606-023-08062-1, 38:12, (2686-2694), Online publication date: 1-Sep-2023. Harris M, Sherrod D, Walsh J, Hunt B, Jacobs J, Valencia J, Baumer-Mouradian S and Quinn K (2023) The Influence of Racism in Healthcare: COVID-19 Vaccine Hesitancy Among Black Mothers in Chicago, Journal of Racial and Ethnic Health Disparities, 10.1007/s40615-023-01708-0 Zuin M, Pinto D, Nguyen T, Chatzizisis Y, Pasquetto G, Daggubati R, Bilato C and Rigatelli G (2023) Trends in Cardiogenic Shock-Related Mortality in Patients With Acute Myocardial Infarction in the United States, 1999 to 2019, The American Journal of Cardiology, 10.1016/j.amjcard.2023.05.026, 200, (18-25), Online publication date: 1-Aug-2023. Benzo R, Moreno P, Fox R, Silvera C, Walsh E, Yanez B, Balise R, Oswald L and Penedo F (2023) Comorbidity burden and health-related quality of life in men with advanced prostate cancer, Supportive Care in Cancer, 10.1007/s00520-023-07962-6, 31:8, Online publication date: 1-Aug-2023. Simon L, Primeaux S, Levitt D, Bourgeois B, Johannsen N, Peters A, Ahmed J, Marshall R, Fairchild A, Ferguson T and Molina P (2023) An aerobic exercise intervention to improve metabolic health among people living with HIV with at-risk alcohol use: the ALIVE-Ex research study protocol, AIDS Research and Therapy, 10.1186/s12981-023-00530-2, 20:1 de Havenon A, Parasuram N, Crawford A, Mazurek M, Chavva I, Yadlapalli V, Iglesias J, Rosen M, Falcone G, Payabvash S, Sze G, Sharma R, Schiff S, Safdar B, Wira C, Kimberly W and Sheth K (2023) Identification of White Matter Hyperintensities in Routine Emergency Department Visits Using Portable Bedside Magnetic Resonance Imaging, Journal of the American Heart Association, 12:11, Online publication date: 6-Jun-2023.Phulka J, Ashraf M, Bajwa B, Pare G and Laksman Z (2023) Current State and Future of Polygenic Risk Scores in Cardiometabolic Disease: A Scoping Review, Circulation: Genomic and Precision Medicine, 16:3, (286-313), Online publication date: 1-Jun-2023. Fleenor B, Carlini N and Martens C (2023) Nutraceuticals in the Prevention and Therapeutic Treatment of Cardiovascular and Cerebrovascular Disease, Journal of Cardiopulmonary Rehabilitation and Prevention, 10.1097/HCR.0000000000000773, 43:3, (162-169), Online publication date: 1-May-2023. Chen F, Wang J, Chen X, Yu L, An Y, Gong Q, Chen B, Xie S, Zhang L, Shuai Y, Zhao F, Chen Y, Li G and Zhang B (2023) Development of models to predict 10-30-year cardiovascular disease risk using the Da Qing IGT and diabetes study, Diabetology & Metabolic Syndrome, 10.1186/s13098-023-01039-4, 15:1 Stabellini N, Cullen J, Bittencourt M, Moore J, Cao L, Weintraub N, Harris R, Wang X, Datta B, Coughlin S, Garcia J, Shanahan J, Hamerschlak N, Waite K, Fillmore N, Terris M, Montero A, Barnholtz-Sloan J and Guha A (2023) Allostatic load and cardiovascular outcomes in males with prostate cancer, JNCI Cancer Spectrum, 10.1093/jncics/pkad005, 7:2, Online publication date: 1-Mar-2023. Son H, Zhang D, Shen Y, Jaysing A, Zhang J, Chen Z, Mu L, Liu J, Rajbhandari‐Thapa J, Li Y and Pagán J (2023) Social Determinants of Cardiovascular Health: A Longitudinal Analysis of Cardiovascular Disease Mortality in US Counties From 2009 to 2018, Journal of the American Heart Association, 12:2, Online publication date: 17-Jan-2023. Freer J, Orr J, Walton R, Storr H, Dunkel L and Prendergast A (2023) Does stunting still matter in high-income countries?, Annals of Human Biology, 10.1080/03014460.2023.2216022, 50:1, (267-273), Online publication date: 2-Jan-2023. Grey C, Brewer K, Ameratunga S, Selak V, Hanchard S, Dicker B, Paynter J, Taueetia-Su'a T, Winter-Smith J, Newport R, Tane T and Harwood M (2023) Manawataki Fatu Fatu for ACCESS (Māori and Pacific Hearts in Unison for Achieving Cardiovascular Care in Equity StudieS). Protocol for a Mixed Methods Programme of Research, International Journal of Qualitative Methods, 10.1177/16094069231176348, 22, (160940692311763), Online publication date: 1-Jan-2023. Mazimba S (2022) Toward equitable utilization of durable left ventricular assist device therapy in advanced heart failure—Raising the veil of health disparities, Journal of Cardiac Surgery, 10.1111/jocs.16933, 37:11, (3595-3597), Online publication date: 1-Nov-2022. Ebinger J, Lan R, Driver M, Rushworth P, Luong E, Sun N, Nguyen T, Sternbach S, Hoang A, Diaz J, Heath M, Claggett B, Bairey Merz C and Cheng S (2022) Disparities in Geographic Access to Cardiac Rehabilitation in Los Angeles County, Journal of the American Heart Association, 11:18, Online publication date: 20-Sep-2022.O'Gallagher K, Teo J, Shah A and Gaughran F (2022) Interaction Between Race, Ethnicity, Severe Mental Illness, and Cardiovascular Disease, Journal of the American Heart Association, 11:12, Online publication date: 21-Jun-2022. De Anda-Duran I, Alonso C, Libon D, Carmichael O, Kolachalama V, Suglia S, Au R and Bazzano L (2022) Carotid Intima-Media Thickness and Midlife Cognitive Function, Neurology, 10.1212/WNL.0000000000200155, 98:18, (e1828-e1836), Online publication date: 3-May-2022. Akam E, Nuako A, Daniel A and Stanford F (2022) Racial Disparities and Cardiometabolic Risk: New Horizons of Intervention and Prevention, Current Diabetes Reports, 10.1007/s11892-022-01451-6, 22:3, (129-136), Online publication date: 1-Mar-2022. Greaves L and Ritz S (2022) Sex, Gender and Health: Mapping the Landscape of Research and Policy, International Journal of Environmental Research and Public Health, 10.3390/ijerph19052563, 19:5, (2563) Liao Y and Brown K (2022) Usage of Digital Health Tools and Perception of mHealth Intervention for Physical Activity and Sleep in Black Women, International Journal of Environmental Research and Public Health, 10.3390/ijerph19031557, 19:3, (1557) September 7, 2021Vol 10, Issue 17 Article InformationMetrics Copyright © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley BlackwellThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.https://doi.org/10.1161/JAHA.121.023650PMID: 34431360 Originally publishedAugust 25, 2021 Keywordsrace/ethnicitydisparitiescardiovascular diseasePDF download SubjectsDisparities
Referência(s)